New Continuous Performance Tests (CPT) for the Diagnosis of Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Computerized continuous performance tests (CPT) considered the "gold standard" for diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD.
This type of tests are based mainly on visual performance. The available tests suffer from high false negative errors. This raises questions regarding their ability to correctly diagnose ADHD.
With the expanding knowledge regarding the neurobiological basis in ADHD we have learned that attention is not a general property of the whole brain, but involves several coordinated networks. This knowledge promoted us to the stage in which we can recognize different types of attention domains.
Our diagnosis test can separate between the different attention abilities and provide specific diagnosis. Our program is individually fits for the specific child difficulties and covers a wider range of needs. So, it can be helpful to a larger variety of children with different needs.
| Condition |
|---|
|
Attention Deficit Hyperactivity Disorder |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | New Computerized Continuous Performance Test (CPT) for Diagnosing Pediatric Attention Deficit/Hyperactivity Disorder (ADHD) |
- accurate diagnosis of ADHD [ Time Frame: one year ] [ Designated as safety issue: Yes ]
- validation [ Time Frame: one year ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 500 |
| Study Start Date: | February 2008 |
| Estimated Study Completion Date: | December 2010 |
| Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
2
Children 6-12 years old diagnosed as not suffering from ADHD
|
|
1
children 6-12 diagnosed as ADHD
|
Detailed Description:
Computerized continuous performance tests (CPT) considered the "gold standard" for diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD) and are widely used.
This type of tests measures the number of correctly detected stimuli as well as response time. The diagnosis in this tests based mainly on visual performance. The available tests in the market suffer from high false negative errors. In some subgroups of children the error can be false positive. All this raises questions regarding their ability to correctly diagnose ADHD. There are also doubts regarding the validity of these tests. From the medical literature and from our own experience it seems that with the current tests as much as third of the children who fulfill DSM criteria for ADHD can escape detection.
With the expanding knowledge regarding the neurobiological basis in ADHD we have learned that attention is not a general property of the whole brain, but involves several coordinated networks. These networks must be orchestrated in order to perform normally in three main domains of attention = alertness, orientation and executive function. This raised the need for a better, more accurate and valid computerized test.
This knowledge promoted us to the stage in which we can recognize different types of attention domains. We can separate between - visual attention, auditory attention, spatial attention, integrated attention, sustained attention, covert and overt attention, working memory, the ability to integrate and disintegrate attention, attention span, focusing, impulsivity and response time. Different people have different "subtypes" of ADHD. The individual separation and ability to focus on specific difficulties influence diagnosis process and treatment methods.
Our diagnosis test can separate between the different attention abilities and provide the parents with specific diagnosis of their child and in this way direct them to the appropriate diagnosis and treatment. Moreover, we expect its falls negative and positive errors to be negligible.
The next phase - involves training and exercise. It is proved that training can improve attention.
We have also developed a computerized training program for children. This program is based on the same platform as the diagnosis test and can recommend on training in the individual difficulties of the specific child.
Other programs are already distributed in the market for the same propose. The other programs focus on improving a general specific skill and ignore (or can not focus) on the specific need of the individual. They can try to improve working memory which is only one aspect in attention domain. Or, based on improving visual-motor skill, which is a skill that can be improved in regular computer games and again focus on a specific short range difficulty. In many children ADHD symptoms and signs are due to other sources. For them improving working memory or visual-motor skills will not change their every day performance.
Our program is better since it is individually fits for the specific child difficulties and covers a wider range of needs. So, it can be helpful to a larger variety of children with different needs.
Eligibility| Ages Eligible for Study: | 6 Years to 12 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
6-12 year old children suspected as ADHD otherwise healthy
Inclusion Criteria:
- diagnosis of ADHD by the "gold standard" method
Exclusion Criteria:
- Chronic use of medications, Psychiatric disorder, Abnormal cognitive function
Contacts and Locations| Contact: Itai Berger, MD | +972-2-5844751 | itberg@hadassah.org.il |
| Contact: Liora Shiloni | +972-2-5845034 | sliora@hadassah.org.il |
| Israel | |
| Neuro-Pediatric Unit, Hadassah-Hebrew University Medical Center | Recruiting |
| Jerusalem, Israel, 91240 | |
| Contact: Itai Berger, MD +972-2-5844751 itberg@hadassah.org.il | |
| Contact: Liora Shiloni +972-2-5845034 sliora@hadassah.org.il | |
| Principal Investigator: Itai Berger, MD | |
| Sub-Investigator: Nir Yachin | |
| Neuro-Pediatric Unit, Hadassah-Hebrew University Medical Center Mount Scopus | Recruiting |
| Jerusalem, Israel, 91240 | |
| Contact: Itai Berger, MD +972-2-5844751 itberg@hadassa.org.il | |
| Contact: Liora Shiloni +972-2-5845034 sliora@hadassah.org.il | |
| Principal Investigator: Itai Berger, MD | |
| Principal Investigator: | Itai Berger, MD | Hadassah Medical Organization |
More Information
Publications:
| Responsible Party: | Itai Berger MD, Hadassah Medical Organization |
| ClinicalTrials.gov Identifier: | NCT00646464 History of Changes |
| Other Study ID Numbers: | 0052-08-HMO-CTIL |
| Study First Received: | March 25, 2008 |
| Last Updated: | August 10, 2009 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Keywords provided by Hadassah Medical Organization:
|
CPT ADHD |
Additional relevant MeSH terms:
|
Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Mental Disorders Diagnosed in Childhood Mental Disorders |
Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on May 19, 2013